AGTC Receives $2 Million Milestone from Genzyme after Successful Transfer of Novel Production Technology.
Linked as:
Extract
AGTC Receives $2 Million Milestone from Genzyme after Successful Transfer of Novel Production Technology.
ALACHUA, Fla. -- AGTC (Applied Genetic Technologies Corporation), a privately held clinical stage gene therapy company, is pleased to announce that it has received a $2 million milestone pay...
See the full content of this document
Sponsored links
